Michael J. Fox Parkinson Foundation: Research Grants – Pre-proposals

Multiple opportunities:

Assay Development and Validation for Quantifying Oligomeric Alpha-Synuclein: for research to advance the development, optimization and validation of assays to quantify oligomeric alpha-synuclein in human body fluids.
Funding: $200,000 for up to 1 year

Biology of Astrocytes in Parkinson’s disease: The goals of this funding program are to further understanding of astrocyte biology in Parkinson’s and to rationalize the pursuit of astrocyte-specific targets and/or pathways for the treatment of the disease.
Funding: $150,000 for 1 year to 18 months

Imaging Biomarkers to Track Disease Progression and Therapeutic Efficacy: grants to develop imaging markers for use in disease-modifying clinical trials.
Funding: $750,000 up to three-year.

Therapeutic Pipeline Program: Seeks to speed the development of Parkinson’s disease therapeutics with potential for fundamentally altering disease course, significantly improving treatment or management of symptoms beyond current standards of care. Proposals should focus on strategies with clear impact for people with PD and well-defined development plans, which can include traditional pharmacological treatments, biological therapies, gene therapy, surgical, non-invasive/non-pharmaceutical or applied technology approaches.
Funding:
Pre-clinical Program - $500,000 up to 2 years
Applied Technology Program - $500,000 up to 2 years
Clinical Program - $2,000,000 up to 3 years

Please contact Research Authority if planning to submit.

https://www.michaeljfox.org/research/apply-for-grant.html?navid=funding-opps&et_cid=1242426&et_rid=225137082&et_lid=https%3a%2f%2fwww.michaeljfox.org%2fresearch%2fapply-for-grant.html%3fnavid%3dfunding-opps&em_cid=